Nonetheless our studies confirm that PTEN mRNA levels are regulated and controlled at least in part by TGF-β1, which supports our hypothesis that the overexpression of TGF-β1 in pancreatic cancer may contribute to reduced PTEN mRNA levels in this malignancy. This evidence concerns the gene PTEN and familial pancreatic carcinoma.